Literature DB >> 1532049

The mRNA 5' cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts.

A Lazaris-Karatzas1, N Sonenberg.   

Abstract

We present evidence that eIF-4E, the mRNA 5' cap-binding protein, cooperates with two immortalizing oncogenes, v-myc and E1A, to cause transformation of rat embryo fibroblasts. eIF-4E alone can transform rat embryo fibroblasts when selection is applied. The pattern of transformation by eIF-4E is similar to that of p21 Ras, raising the possibility that eIF-4E shares a common signal transduction pathway with p21 Ras.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532049      PMCID: PMC369555          DOI: 10.1128/mcb.12.3.1234-1238.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

Review 1.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

Authors:  R A Weinberg
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

Review 2.  Protein phosphorylation controls translation rates.

Authors:  J W Hershey
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

3.  Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F.

Authors:  F Rozen; I Edery; K Meerovitch; T E Dever; W C Merrick; N Sonenberg
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

4.  Differential stimulation of phosphorylation of initiation factors eIF-4F, eIF-4B, eIF-3, and ribosomal protein S6 by insulin and phorbol esters.

Authors:  S J Morley; J A Traugh
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

5.  Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts.

Authors:  J C Reed; S Haldar; C M Croce; M P Cuddy
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

6.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

7.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.

Authors:  A Lazaris-Karatzas; K S Montine; N Sonenberg
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

8.  Cap recognition and the entry of mRNA into the protein synthesis initiation cycle.

Authors:  R E Rhoads
Journal:  Trends Biochem Sci       Date:  1988-02       Impact factor: 13.807

9.  Regulation of rat ornithine decarboxylase mRNA translation by its 5'-untranslated region.

Authors:  J M Manzella; P J Blackshear
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

10.  Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences.

Authors:  P T Kirschmeier; G M Housey; M D Johnson; A S Perkins; I B Weinstein
Journal:  DNA       Date:  1988-04
View more
  53 in total

1.  Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitro.

Authors:  M Gao; D T Fritz; L P Ford; J Wilusz
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

2.  The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.

Authors:  Ivan Topisirovic; Biljana Culjkovic; Natalie Cohen; Jacqueline M Perez; Lucy Skrabanek; Katherine L B Borden
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

3.  Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts.

Authors:  Darren J Perkins; Glen N Barber
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

4.  Isolation and sequence of a cDNA encoding the cap binding protein of wheat eukaryotic protein synthesis initiation factor 4F.

Authors:  A M Metz; R T Timmer; K S Browning
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

Review 5.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

6.  Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation.

Authors:  W K Miskimins; G Wang; M Hawkinson; R Miskimins
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.

Authors:  Priam Villalonga; Silvia Fernández de Mattos; Anne J Ridley
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death.

Authors:  N Levy-Strumpf; L P Deiss; H Berissi; A Kimchi
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

9.  Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.

Authors:  Ivan Topisirovic; Allan D Capili; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.

Authors:  R Shen; Z Z Su; C A Olsson; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.